# Targeted Clinical Research Program to Address Selected Viral Infections

> **NIH NIH N01** · FRED HUTCHINSON CANCER CENTER · 2024 · $237,480

## Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients and includes a Phase II clinical trial.

## Key facts

- **NIH application ID:** 11041790
- **Project number:** 272201600015C-P00013-9999-1
- **Recipient organization:** FRED HUTCHINSON CANCER CENTER
- **Principal Investigator:** MICHAEL BOECKH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $237,480
- **Award type:** —
- **Project period:** 2016-07-01 → 2025-01-02

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11041790

## Citation

> US National Institutes of Health, RePORTER application 11041790, Targeted Clinical Research Program to Address Selected Viral Infections (272201600015C-P00013-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11041790. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*